Missouri, Kansas and Idaho can press forward with their lawsuit to restrict access to the abortion drug mifepristone, a federal judge ruled Thursday, months after the US Supreme Court had rejected an earlier version of the legal challenge.

The three states argue that the FDA's approval of mifepristone for use up to 10 weeks of pregnancy, along with its availability via telemedicine and mail, has contributed to what they view as a public health risk.

A Texas judge has allowed Idaho, Kansas, and Missouri to challenge federal rules on the abortion drug mifepristone. The states want stricter regulations, citing conflict with state abortion laws. The case continues despite a prior Supreme Court decision maintaining access to the drug.

After abortion opponents and doctors failed in their case to have the drug restricted — the Supreme Court ruled they lacked standing — Idaho, Kansas, and Missouri stepped in. Meanwhile, other states are making moves to protect reproductive rights.

A Texas judge has allowed three states to move forward with a legal challenge seeking to impose stricter rules on the abortion pill mifepristone, reigniting the battle over medication abortion access in the U.

Trump-appointed Judge Matthew Kacsmaryk ruled Thursday that Idaho, Kansas, and Missouri can pursue legal action to prohibit the FDA from allowing online prescriptions.

The Republican-led states of Idaho, Missouri and Kansas can proceed with a lawsuit seeking to restrict the availability of the abortion pill mifepristone in the United States, a federal judge in Texas ruled on Thursday.

The states of Idaho, Kansas and Missouri made the request in U.S. District Court in Amarillo, Texas. The only judge based there is Matthew Kacsmaryk, a nominee of former President Donald Trump who previously ruled in favor of a challenge to the pill’s approval.